RG-7112

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRG-7112
Drug Alias NameR-7112R-1772RG-7112RO-5045337
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsHematologic NeoplasmsSarcomaLeukemia, Myeloid, Acute +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[5] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsSarcomaLeukemia, Myeloid, Acute +[5] 

Other Information

ATC CodeN/A
Related LinksN/A